Page 70 - 南京医科大学自然版
P. 70

第44卷第8期
               ·1098 ·                           南 京    医 科 大 学 学         报                        2024年8月


              反映实际情况;第三,肝脏状况评估基于瞬时弹性成                           [11]LEE J,VALI Y,BOURSIER J,et al. Prognostic accuracy
              像技术诊断,而非金标准肝活检,可能存在偏差。                                 of FIB⁃4,NAFLD fibrosis score and APRI for NAFLD⁃re⁃
                                                                     lated events:a systematic review[J]. Liver Int,2021,41
                  综上,年龄、性别、臀围、铁蛋白、AST、GGT、CMI
              均是 NAFLD患者出现肝脏显著纤维化的独立危险因                             (2):261-270
                                                                [12]GRAUPERA I,THIELE M,SERRA⁃BURRIEL M,et al.
              素。aCHANGE模型是基于逐步Logistic回归构建的
                                                                     Low accuracy of FIB ⁃ 4 and NAFLD fibrosis scores for
              临床预测模型,在训练集和验证集中均具有良好的区
                                                                     screening for liver fibrosis in the population[J]. Clin Gas⁃
              分度、准确性和临床实用性。该临床模型有助于预测                                troenterol Hepatol,2022,20(11):2567-2576
              NAFLD患者出现显著肝脏纤维化的风险。                              [13]WAKABAYASHI I,DAIMON T. The“cardiometabolic in⁃

             [参考文献]                                                  dex”as a new marker determined by adiposity and blood
                                                                     lipids for discrimination of diabetes mellitus[J]. Clin
             [1] POWELL E E,WONG V W,RINELLA M. Non⁃alcoholic
                                                                     Chim Acta,2015,438:274-278
                   fatty liver disease[J]. Lancet,2021,397(10290):2212-
                                                                [14]DURSUN M,BESIROGLU H,OTUNCTEMUR A,et al.
                   2224
                                                                     Association between cardiometabolic index and erectile
             [2] ALLEN A M,LAZARUS J V,YOUNOSSI Z M. Health⁃
                                                                     dysfunction:a new index for predicting cardiovascular dis⁃
                   care and socioeconomic costs of NAFLD:a global frame⁃
                                                                     ease[J]. Kaohsiung J Med Sci,2016,32(12):620-623
                   work to navigate the uncertainties[J]. J Hepatol,2023,79
                                                                [15]WANG H Y,SHI W R,YI X,et al. Value of reduced glo⁃
                  (1):209-217
                                                                     merular filtration rate assessment with cardiometabolic in⁃
             [3] YOUNOSSI Z M,GOLABI P,PAIK J M,et al. The global
                                                                     dex:insights from a population⁃based Chinese cohort[J].
                   epidemiology of nonalcoholic fatty liver disease(NAFLD)
                                                                     BMC Nephrol,2018,19(1):294
                   and nonalcoholic steatohepatitis(NASH):a systematic re⁃
                                                                [16]WANG H,CHEN Y,SUN G,et al. Validity of cardiometa⁃
                   view[J]. Hepatology,2023,77(4):1335-1347
                                                                     bolic index,lipid accumulation product,and body adiposi⁃
             [4] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中
                                                                     ty index in predicting the risk of hypertension in Chinese
                   国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性
                                                                     population[J]. Postgrad Med,2018,130(3):325-333
                   肝病防治指南(2018 更新版)[J]. 中华肝脏病杂志,
                                                                [17]ZUO Y Q,GAO Z H,YIN Y L,et al. Association between
                   2018,26(3):195-203
                                                                     the cardiometabolic index and hyperuricemia in an as⁃
             [5] TARGHER G,BYRNE C D,TILG H. NAFLD and in⁃
                                                                     ymptomatic population with normal body mass index[J].
                   creased risk of cardiovascular disease:clinical associa⁃
                                                                     Int J Gen Med,2021,14:8603-8610
                   tions,pathophysiological mechanisms and pharmacologi⁃  [18]ZOU J,XIONG H,ZHANG H,et al. Association between
                   cal implications[J]. Gut,2020,69(9):1691-1705     the cardiometabolic index and non ⁃ alcoholic fatty liver
             [6] CHAKRABORTY D,WANG J. Nonalcoholic fatty liver      disease:insights from a general population[J]. BMC Gas⁃
                   disease and colorectal cancer:correlation and missing  troenterol,2022,22(1):20
                   links[J]. Life Sci,2020,262:118507           [19]BASILE⁃FILHO A,LAGO A F,MENEGUETI M G,et al.
             [7] PARIZADEH S M,PARIZADEH S A,ALIZADE ⁃               The use of APACHE Ⅱ,SOFA,SAPS 3,C⁃reactive pro⁃
                   NOGHANI M,et al. Association between non ⁃ alcoholic  tein/albumin ratio,and lactate to predict mortality of surgi⁃
                   fatty liver disease and colorectal cancer[J]. Expert Rev  cal critically ill patients:a retrospective cohort study[J].
                   Gastroenterol Hepatol,2019,13(7):633-641          Medicine,2019,98(26):e16204
             [8] SONG S J,LAI J C,WONG G L,et al. Can we use old  [20]SHIBUTANI M,MAEDA K,NAGAHARA H,et al. Prog⁃
                   NAFLD data under the new MASLD definition?[J]. J  nostic significance of the preoperative ratio of C⁃reactive
                   Hepatol,2024,80(2):e54-e56                        protein to albumin in patients with colorectal cancer[J].
             [9] HAGSTRÖM H,VESSBY J,EKSTEDT M,et al. 99% of         Anticancer Res,2016,36(3):995-1001
                   patients with NAFLD meet MASLD criteria and natural  [21]LIN N,LI J,KE Q,et al. Clinical significance of C⁃reac⁃
                   history is therefore identical[J]. J hepatol,2024,80(2):  tive protein to albumin ratio in patients with hepatocellu⁃
                   e76-e77                                           lar carcinoma:a meta ⁃ analysis[J]. Dis Markers,2020,
             [10]ANGULO P,KLEINER D E,DAM⁃LARSEN S,et al. Liv⁃       2020:4867974
                   er fibrosis,but no other histologic features,is associated  [22]BAO Y,YANG J,DUAN Y,et al. The C⁃reactive protein
                   with long⁃term outcomes of patients with nonalcoholic fat⁃  to albumin ratio is an excellent prognostic predictor for
                   ty liver disease[J]. Gastroenterology,2015,149(2):389-  gallbladder cancer[J]. Biosci Trends,2021,14(6):428-
                   397                                               435
   65   66   67   68   69   70   71   72   73   74   75